VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 63 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,675,435 | -48.3% | 285,532 | +35.4% | 0.00% | -50.0% |
Q2 2023 | $5,171,611 | +82.0% | 210,828 | +72.6% | 0.00% | +100.0% |
Q1 2023 | $2,841,872 | -61.2% | 122,126 | -57.8% | 0.00% | -66.7% |
Q4 2022 | $7,332,991 | +263.9% | 289,727 | +177.2% | 0.00% | +200.0% |
Q3 2022 | $2,015,000 | -37.6% | 104,528 | -17.6% | 0.00% | 0.0% |
Q2 2022 | $3,231,000 | -60.9% | 126,875 | -60.5% | 0.00% | -66.7% |
Q1 2022 | $8,258,000 | +106.0% | 321,053 | +235.5% | 0.00% | +200.0% |
Q4 2021 | $4,008,000 | +353.4% | 95,707 | +370.7% | 0.00% | – |
Q3 2021 | $884,000 | -14.2% | 20,332 | -6.7% | 0.00% | – |
Q2 2021 | $1,030,000 | -42.6% | 21,791 | -37.7% | 0.00% | -100.0% |
Q1 2021 | $1,793,000 | +47.2% | 34,976 | -23.1% | 0.00% | – |
Q4 2020 | $1,218,000 | -45.8% | 45,491 | -30.5% | 0.00% | -100.0% |
Q3 2020 | $2,246,000 | +46.5% | 65,421 | +74.8% | 0.00% | 0.0% |
Q2 2020 | $1,533,000 | +972.0% | 37,428 | +793.9% | 0.00% | – |
Q1 2020 | $143,000 | -4.7% | 4,187 | -65.0% | 0.00% | – |
Q4 2019 | $150,000 | – | 11,957 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |